Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial
PaperCitations, authors & open-access status
Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 106 citations, 2020 year and hybrid oa status.
106
Citations
2020
Year
hybrid
OA Status